Managers / Q4 2018 · view latest →
BB BIOTECH AG
CIK 0000924223 · SCHWERTSTRASSE 6, SCHAFFHAUSEN, 8200 · 411724 59 59
Reported Value
$3.1B
Q4 2018
Positions
34
Filings on Record
2
2019–present window
Filed
Feb 12, 2019
original filing
Summary
Bb Biotech Ag reported $3.1B in U.S.-listed holdings across 34 positions for Q4 2018.
Its largest position, ISI, represents 15.1% of the portfolio.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 92.1% · $2.9B
- Other · 5.1% · $161M
- ADR · 2.7% · $85M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2018
Filing History
Other Included Managers
This filing reports holdings on behalf of 4 additional managers.
- Biotech Focus N V28-11193
- Biotech Invest N V28-11191
- Biotech Target N V28-11189
- Biotech Growth N V28-11194
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.